Table 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation

We only have this paper's title and publication details.

TCR–T cell therapy shows promise for treating recurrent HBV-related HCC after liver transplantation, suggesting potential benefits and risks.